Cargando…
Doxorubicin-loaded Drug-eluting beads Versus Conventional Transarterial Chemoembolization for Nonresectable Hepatocellular Carcinoma
BACKGROUND/AIMS: To compare the efficacy and safety profile of doxorubicin-loaded drug-eluting beads (DEB) to the conventional TACE (C-TACE) in the management of nonresectable hepatocellular carcinoma (HCC). PATIENTS AND METHODS: All patients with nonresectable HCC who underwent either c-TACE or DEB...
Autores principales: | Arabi, Mohammad, BenMousa, Ali, Bzeizi, Khaled, Garad, Fares, Ahmed, Ishtiaq, Al-Otaibi, Melfi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455148/ https://www.ncbi.nlm.nih.gov/pubmed/26021777 http://dx.doi.org/10.4103/1319-3767.157571 |
Ejemplares similares
-
Doxorubicin-loaded Drug-eluting beads Versus Conventional Transarterial Chemoembolization for Nonresectable Hepatocellular Carcinoma: Erratum
Publicado: (2015) -
Conventional Transarterial Chemoembolization Versus Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Bzeizi, Khalid I., et al.
Publicado: (2021) -
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
por: Kloeckner, Roman, et al.
Publicado: (2015) -
Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
por: Baur, Johannes, et al.
Publicado: (2016) -
Conventional vs drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma
por: Song, Jeong Eun, et al.
Publicado: (2017)